After enduring a tragic childhood, losing his mother, and navigating financial ruin with his father during South Korea’s 1997 financial crisis, Si-heon immigrates to the U.S. He fulfills his father’s wish by becoming a doctor but finds himself drawn to the lucrative world of Wall Street. At a top hedge fund, Si-heon leverages his medical expertise to dominate biotech investments, thanks to an unusual ability to predict successful FDA drug approvals. He amasses wealth quickly, yet struggles with a pathological fear of spending money. His relentless pursuit of profit takes a dark turn when he’s diagnosed with idiopathic multicentric Castleman’s disease (iMCD), a rare, life-threatening immune disorder with no cure. His condition worsens despite aggressive chemotherapy, as the lack of research funding for this “orphan disease” leaves him without options. Just as Si-heon faces death, he miraculously awakens to find himself transported 10 years back in time, to the beginning of his career on Wall Street. Realizing he has a second chance, Si-heon is determined to not only reclaim his wealth but also amass enough money to fund a cure for iMCD. The story explores themes of greed, ambition, mortality, and redemption, as Si-heon seeks not just to survive but to redefine the meaning of his life.